[Cost-effective treatment with ondansetron].
Glaxo
A S
AS
D003362:Cost-Benefit Analysis; D006801:Humans; D009664:Norway; D017294:Ondansetron / Q000191:economics* / Q000627:therapeutic use
D017294:Ondansetron
Kostnadseffektiv behandling med ondansetron.